Vasoactive Intestinal Peptide (VIP) 5mg adds a well-established neuropeptide to the Alpha Peptide Research Healing Peptides collection.

VIP is a naturally occurring 28-amino-acid peptide that functions as a signaling molecule in several biological systems. Scientists have investigated VIP extensively because of its involvement in communication between the nervous, immune, vascular, and gastrointestinal systems.

Furthermore, VIP research demonstrates how one peptide can participate in several interconnected signaling networks. Researchers have therefore examined it in experimental models involving neuronal communication, immune-cell activity, vascular responses, gastrointestinal physiology, and cellular signaling.

The broad research profile of VIP makes it a useful addition to a collection focused on peptides with important roles in cellular and tissue biology.

Alpha Peptide Research supplies VIP 5mg strictly for controlled laboratory research.

What Is VIP?

VIP stands for Vasoactive Intestinal Peptide.

It is a 28-amino-acid neuropeptide belonging to the secretin/glucagon peptide family. Researchers originally identified VIP in studies involving the gastrointestinal nervous system, but subsequent research revealed activity across multiple biological systems.

VIP occurs naturally in the nervous system and in several peripheral tissues.

Consequently, scientists have investigated VIP as both a neuropeptide and a broader signaling molecule.

Its receptors belong primarily to the class B family of G protein-coupled receptors, including VPAC1 and VPAC2.

As a result, VIP research provides opportunities to examine receptor-mediated signaling across different cell types.

VIP Sequence

VIP is commonly described as a 28-amino-acid peptide.

Its sequence is:

HSDAVFTDNYTRLRKQMAVKKYLNSILN

Researchers working with VIP should verify the identity and characterization of the specific material used in an experiment.

In particular, batch-specific analytical documentation can help distinguish native VIP from modified peptide analogs or related neuropeptides.

VIP and Neurobiology

VIP has an important research history in neurobiology.

Neurons use numerous chemical messengers to communicate with neighboring cells and tissues. Neuropeptides form one part of this communication system.

VIP is expressed in various neuronal populations and has been investigated in experimental models of neuronal signaling.

For example, researchers can examine VIP-associated receptor activity, intracellular signaling, or changes in cellular responses following controlled exposure.

Additionally, VIP can be studied alongside other neurotransmitters and neuropeptides to investigate interactions between signaling systems.

VIP Receptors

VIP primarily interacts with two well-characterized receptors:

• VPAC1
• VPAC2

Both receptors belong to the class B family of G protein-coupled receptors.

When VIP interacts with these receptors, downstream signaling can involve intracellular pathways such as cyclic AMP.

Therefore, VIP provides researchers with a useful experimental model for studying peptide-receptor interactions.

Laboratories can investigate receptor expression, ligand binding, intracellular signaling, and downstream cellular responses.

VIP and Cellular Signaling

Cellular signaling allows cells to respond to their environment and communicate with one another.

VIP participates in signaling through receptor-mediated pathways.

Consequently, researchers can use VIP to investigate how activation of specific receptors influences cellular behavior.

Experimental systems may measure intracellular messenger levels, protein phosphorylation, gene expression, or other defined molecular endpoints.

Furthermore, comparing VPAC1- and VPAC2-associated responses can help researchers explore differences between receptor systems.

VIP and Immune Research

The nervous and immune systems communicate through complex networks of signaling molecules.

VIP has attracted considerable research interest within this field because immune cells can express receptors associated with VIP signaling.

Researchers have therefore investigated VIP in experimental models involving immune-cell communication.

For instance, laboratory studies may examine changes in cytokine-associated signaling or immune-cell responses under controlled conditions.

Additionally, researchers can compare different cell types to determine whether VIP-associated responses vary according to receptor expression or cellular environment.

VIP and Inflammatory Pathway Research

Inflammatory responses involve numerous signaling molecules and cell types.

Researchers study these pathways to understand how immune and non-immune cells coordinate responses to different biological conditions.

VIP has been investigated in experimental models involving inflammatory signaling.

However, inflammatory biology is highly context-dependent. A response observed in one experimental system may not occur in another.

Therefore, researchers should evaluate VIP using appropriate controls and multiple experimental endpoints.

This approach can provide a more complete picture of peptide-associated signaling.

VIP and Vascular Biology

The name Vasoactive Intestinal Peptide reflects early observations involving vascular activity.

VIP research has consequently included studies of vascular smooth muscle and blood-vessel-related signaling.

Researchers can investigate how VIP interacts with vascular receptors and intracellular signaling pathways.

Moreover, experimental vascular models can provide information about peptide-receptor relationships and cellular responses.

These studies contribute to fundamental research into vascular signaling.

VIP and Gastrointestinal Research

VIP has a long research history involving gastrointestinal physiology.

The peptide is present within the enteric nervous system, where neuropeptides participate in communication between neurons and gastrointestinal tissues.

As a result, researchers have investigated VIP in experimental models involving gastrointestinal signaling and smooth-muscle biology.

Laboratories may examine receptor activity, intracellular signaling, or tissue responses under controlled conditions.

Furthermore, VIP research helps illustrate the close relationship between the nervous system and gastrointestinal function.

VIP and Smooth-Muscle Research

Smooth muscle exists in several tissues throughout the body.

Its activity depends on complex interactions among receptors, signaling molecules, ions, and intracellular pathways.

VIP has been investigated in experimental models involving smooth-muscle signaling.

For example, researchers may study peptide-associated changes in isolated tissue or cellular models.

Such experiments can help clarify how neuropeptides interact with smooth-muscle signaling systems.

VIP and Neuroimmune Communication

Neuroimmune communication describes the extensive signaling network connecting nervous and immune systems.

VIP is particularly interesting within this field because it can participate in both neural and immune-related signaling.

Consequently, researchers may investigate VIP in models designed to examine communication between neurons and immune cells.

These studies can involve receptor analysis, cytokine measurements, cellular signaling assays, or other experimental techniques.

In addition, researchers can examine how different cellular environments influence VIP-associated responses.

VIP and Tissue Biology

Tissues contain multiple interacting cell types.

Neuropeptides such as VIP can participate in communication between these cells.

Researchers therefore investigate VIP in tissue models to better understand peptide signaling in complex biological environments.

For instance, experiments may evaluate receptor distribution or tissue-associated cellular responses.

Moreover, tissue models can provide information that isolated cell systems cannot fully reproduce.

VIP and Cellular Communication

Peptides provide cells with molecular signals that can influence cellular behavior.

VIP represents an example of a neuropeptide that can communicate through specific receptors.

As a result, researchers can use VIP to investigate ligand-receptor interactions and downstream signaling.

Experiments may examine receptor activation, intracellular messenger systems, and changes in selected cellular markers.

Furthermore, VIP can be compared with related peptides to explore differences in receptor selectivity and signaling.

VIP vs. PACAP

VIP and pituitary adenylate cyclase-activating polypeptide (PACAP) are closely related neuropeptides.

Both belong to the secretin/glucagon peptide family and can interact with related receptor systems.

However, they are distinct peptides with different sequences and receptor preferences.

Therefore, researchers should not treat VIP and PACAP as interchangeable materials.

Comparative research involving the two peptides can instead provide useful information about peptide-receptor selectivity and downstream signaling.

VIP vs. GLP-1

VIP and GLP-1 are also members of the broader secretin/glucagon peptide family.

However, their biological roles and research applications differ substantially.

GLP-1 research focuses heavily on metabolic and pancreatic signaling, while VIP has a broader research history involving neurobiology, gastrointestinal signaling, vascular biology, and immune communication.

Consequently, laboratories should select the peptide according to the specific research question.

VIP vs. LL-37

VIP and LL-37 represent very different peptide research areas.

LL-37 is a 37-amino-acid human cathelicidin extensively studied in antimicrobial and innate immune research.

VIP is a 28-amino-acid neuropeptide primarily investigated through receptor-mediated signaling involving neural, immune, vascular, and gastrointestinal systems.

Therefore, the two products complement rather than duplicate each other within the Healing Peptides collection.

Why Choose VIP 5mg?

VIP 5mg provides laboratories with a defined neuropeptide for controlled research involving cellular and tissue signaling.

Key characteristics include:

• 5mg research presentation
• 28-amino-acid peptide
• Naturally occurring neuropeptide
• VIP receptor research
• Neurobiology research
• Immune signaling research
• Cellular communication research
• Inflammatory pathway research
• Vascular biology research
• Gastrointestinal research
• Smooth-muscle research
• Neuroimmune research
• Professional laboratory presentation
• Research Use Only labeling
• Not intended for human consumption

Overall, VIP brings a strong neuropeptide research dimension to the Healing Peptides category.

Product Specifications

VIP 5mg Research Presentation

The 5mg presentation provides laboratories with a clearly identified quantity of VIP research material.

Researchers may investigate VIP using appropriately designed biochemical, cellular, tissue, or receptor-based models.

For example, experiments may focus on receptor signaling, intracellular pathways, immune-cell communication, vascular biology, or gastrointestinal signaling.

Furthermore, suitable controls allow researchers to distinguish peptide-associated responses from experimental background effects.

The 5mg designation identifies the quantity of research material supplied. It does not represent a human dose or administration recommendation.

Quality and Analytical Documentation

Reliable peptide characterization supports reproducible laboratory research.

For this reason, researchers should review batch-specific analytical documentation before using VIP 5mg.

Relevant information may include:

• Peptide identity
• Sequence confirmation
• Analytical purity
• Molecular characterization
• Batch number
• Quantity
• Manufacturing information where applicable

Additionally, researchers should verify whether the material represents native VIP or a modified analog before comparing experimental results with published research.

Exact purity percentages should only be published when supported by appropriate batch-specific testing.

Likewise, statements about third-party testing, certifications, or manufacturing standards should appear only when supporting documentation exists.

Storage and Laboratory Handling

Researchers should follow the validated storage requirements supplied for the specific VIP 5mg formulation and batch.

Keep the vial securely closed and protect the research material from unsuitable environmental conditions.

In addition, laboratories should maintain accurate inventory and batch records.

Qualified personnel should handle research peptides according to established laboratory procedures.

Any temperature displayed on the product label should correspond with verified storage documentation for the supplied formulation.

Controlled Laboratory Research

VIP 5mg is intended for controlled scientific investigation.

Potential research areas include:

• Neurobiology
• Neuropeptide signaling
• VPAC receptor research
• Immune-cell signaling
• Inflammatory pathway research
• Vascular biology
• Gastrointestinal physiology
• Smooth-muscle research
• Neuroimmune communication
• Cellular signaling

For instance, researchers may expose appropriate experimental systems to VIP and measure predefined molecular or cellular endpoints.

Moreover, laboratories can compare VIP-associated responses with those produced by related peptides.

Careful experimental design remains essential when interpreting research results.

Research Use Only

Alpha Peptide Research supplies VIP 5mg exclusively for scientific and laboratory research.

The product is not intended for human consumption, self-administration, diagnosis, therapeutic use, treatment of inflammation, treatment of gastrointestinal disorders, vascular treatment, or veterinary use.

Furthermore, VIP 5mg should not be marketed as a treatment for any disease or medical condition.

The 5mg designation describes research quantity only and does not provide dosing or administration guidance.

Frequently Asked Questions

What is VIP 5mg?

VIP 5mg is a laboratory research presentation containing 5mg of Vasoactive Intestinal Peptide for controlled scientific investigation.

What does VIP stand for?

VIP stands for Vasoactive Intestinal Peptide.

How many amino acids does VIP contain?

VIP is a 28-amino-acid peptide.

What type of peptide is VIP?

VIP is a naturally occurring neuropeptide belonging to the secretin/glucagon peptide family.

What receptors does VIP interact with?

VIP primarily interacts with the VPAC1 and VPAC2 receptors.

Why do scientists study VIP?

Researchers study VIP in neurobiology, cellular signaling, immune communication, vascular biology, gastrointestinal physiology, and related areas.

Is VIP studied in neurobiology?

Yes. VIP has an extensive research history involving neuronal signaling and neuropeptide biology.

Is VIP studied in immune research?

Yes. Researchers have investigated VIP-associated signaling in experimental immune-cell models.

Is VIP studied in gastrointestinal research?

Yes. VIP has been extensively investigated within gastrointestinal and enteric nervous system research.

Is VIP studied in vascular research?

Yes. Vascular signaling represents an important area of VIP research.

Is VIP the same as PACAP?

No. VIP and PACAP are related neuropeptides, but they have different sequences and receptor characteristics.

Is VIP the same as GLP-1?

No. Both belong to the broader secretin/glucagon peptide family, but they have different structures and research profiles.

Is VIP the same as LL-37?

No. LL-37 is a cathelicidin antimicrobial peptide, whereas VIP is a neuropeptide involved in receptor-mediated signaling.

What does 5mg mean?

The 5mg designation indicates the quantity of research material supplied in the vial. It does not represent a recommended dose.

Can VIP 5mg be used by humans?

No. Alpha Peptide Research supplies VIP 5mg strictly for laboratory research and not for human consumption or self-administration.

VIP 5mg From Alpha Peptide Research

VIP 5mg adds a well-established neuropeptide research material to the Alpha Peptide Research Healing Peptides collection.

Its 28-amino-acid structure and interactions with VPAC receptor systems have made VIP an important subject in research involving neurobiology, cellular communication, immune signaling, vascular biology, and gastrointestinal physiology.

Furthermore, VIP complements the immune-focused products already present in the collection while introducing a stronger neuropeptide and receptor-signaling focus.

The 5mg presentation provides a clearly identified research quantity for appropriately designed laboratory experiments.

Overall, VIP 5mg gives researchers another useful tool for investigating communication between neural, immune, vascular, and gastrointestinal systems.

VIP 5mg is for laboratory research only and is not intended for human consumption.